{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T02:57:10Z","timestamp":1774839430498,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s43441-022-00388-y","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T10:02:21Z","timestamp":1646820141000},"page":"433-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Statistical Modeling for Quality Risk Assessment of Clinical Trials: Follow-Up at the Era of Remote Auditing"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4585-7799","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Koneswarakantha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4545-6944","authenticated-orcid":false,"given":"Timoth\u00e9","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"388_CR1","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s43441-020-00147-x","volume":"54","author":"B Koneswarakantha","year":"2020","unstructured":"Koneswarakantha B, M\u00e9nard T, Rolo D, et al. Harnessing the power of quality assurance data: can we use statistical modeling for quality risk assessment of clinical trials? Ther Innov Regul Sci. 2020;54:1227\u201335. https:\/\/doi.org\/10.1007\/s43441-020-00147-x.","journal-title":"Ther Innov Regul Sci"},{"key":"388_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s43441-020-00205-4","volume":"55","author":"M Zou","year":"2021","unstructured":"Zou M, Barmaz Y, Preovolos M, et al. Using statistical modeling for enhanced and flexible pharmacovigilance audit risk assessment and planning. Ther Innov Regul Sci. 2021;55:190\u20136. https:\/\/doi.org\/10.1007\/s43441-020-00205-4.","journal-title":"Ther Innov Regul Sci"},{"issue":"4","key":"388_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/biomet\/87.4.954","volume":"87","author":"IK Yeo","year":"2000","unstructured":"Yeo IK, Johnson RA. A new family of power transformations to improve normality or symmetry. Biometrika. 2000;87(4):95. https:\/\/doi.org\/10.1093\/biomet\/87.4.954.","journal-title":"Biometrika"},{"key":"388_CR4","doi-asserted-by":"crossref","unstructured":"James G, Witten D, Hastie T, Tibshirani R. An introduction to statistical learning. New York: Springer; 2013.","DOI":"10.1007\/978-1-4614-7138-7"},{"key":"388_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ins.2011.12.028","volume":"191","author":"C Bergmeir","year":"2012","unstructured":"Bergmeir C, Ben\u00edtez JM. On the use of cross-validation for time series predictor evaluation. Inf Sci. 2012;191:192\u2013213. https:\/\/doi.org\/10.1016\/j.ins.2011.12.028.","journal-title":"Inf Sci"},{"issue":"1","key":"388_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1175\/1520-0493(1950)078%3C0001:VOFEIT%3E2.0.CO;2","volume":"78","author":"GW Brier","year":"1950","unstructured":"Brier GW. Verification of forecasts expressed in terms of probability. Month Weather Rev. 1950;78(1):1\u20133. https:\/\/doi.org\/10.1175\/1520-0493(1950)078%3C0001:VOFEIT%3E2.0.CO;2.","journal-title":"Month Weather Rev"},{"key":"388_CR7","doi-asserted-by":"publisher","unstructured":"Bleiberg H, Decoster G, de Gramont A et al. A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group. Ann Oncol. 2018;28(5):922\u2013930. https:\/\/doi.org\/10.1093\/annonc\/mdx050.","DOI":"10.1093\/annonc\/mdx050"},{"key":"388_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2020.100662","author":"T M\u00e9nard","year":"2020","unstructured":"M\u00e9nard T, Bowling R, Mehta P, et al. Leveraging analytics to assure quality during the Covid-19 pandemic: the COVACTA clinical study example. Contem Clin Trials Commun. 2020. https:\/\/doi.org\/10.1016\/j.conctc.2020.100662.","journal-title":"Contem Clin Trials Commun"},{"key":"388_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12677","author":"T M\u00e9nard","year":"2021","unstructured":"M\u00e9nard T, Young K, Emerson J, et al. Cross-company collaboration to leverage analytics for clinical quality and accelerate drug development: the IMPALA industry group. CPT Pharmacometrics Syst Pharmacol. 2021. https:\/\/doi.org\/10.1002\/psp4.12677.","journal-title":"CPT Pharmacometrics Syst Pharmacol"}],"container-title":["Therapeutic Innovation &amp; Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-022-00388-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-022-00388-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-022-00388-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:25:10Z","timestamp":1744183510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-022-00388-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["388"],"URL":"https:\/\/doi.org\/10.1007\/s43441-022-00388-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.12.21260214","asserted-by":"object"}]},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bj\u00f6rn Koneswarakantha and Timoth\u00e9 M\u00e9nard were employed by Roche at the time this research was conducted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All human subject data used in this analysis were used in a de-identified format. Ethics approval is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}